HEADER SIGNALING PROTEIN 30-SEP-09 2KOT TITLE SOLUTION STRUCTURE OF S100A13 WITH A DRUG AMLEXANOX COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN S100-A13; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: S100 CALCIUM-BINDING PROTEIN A13; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: S100A13; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PGEX-4T KEYWDS S100A13, SIGNALING PROTEIN, CALCIUM, PHOSPHOPROTEIN EXPDTA SOLUTION NMR NUMMDL 18 AUTHOR S.G.RANI,S.K.MOHAN,C.YU REVDAT 1 09-MAR-10 2KOT 0 JRNL AUTH S.G.RANI,S.K.MOHAN,C.YU JRNL TITL MOLECULAR LEVEL INTERACTIONS OF S100A13 WITH JRNL TITL 2 AMLEXANOX: INHIBITOR FOR THE FORMATION OF JRNL TITL 3 MULTI-PROTEIN COMPLEX IN NON-CLASSICAL PATHWAY OF JRNL TITL 4 THE ACIDIC FIBROBLAST GROWTH FACTOR JRNL REF BIOCHEMISTRY 2010 JRNL REFN ISSN 0006-2960 JRNL PMID 20178375 JRNL DOI 10.1021/BI9019077 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ARIA 2.2 REMARK 3 AUTHORS : LINGE, O'DONOGHUE, NILGES REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ARIA/CNS REMARK 4 REMARK 4 2KOT COMPLIES WITH FORMAT V. 3.20, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 13-OCT-09. REMARK 100 THE RCSB ID CODE IS RCSB101386. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 5.6 REMARK 210 IONIC STRENGTH : 0.1 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.2MM [U-100% 13C; U-100% REMARK 210 15N] PROTEIN S100-A13, 1.2MM REMARK 210 AMLEXANOX-2, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C REMARK 210 HSQC; 2D 1H-1H NOESY; 3D REMARK 210 CBCA(CO)NH; 3D C(CO)NH; 3D REMARK 210 HNCO; 3D HNCA; 3D HBHA(CO)NH; REMARK 210 3D H(CCO)NH; 3D HCCH-TOCSY; 3D REMARK 210 1H-15N NOESY; 3D 1H-13C NOESY; REMARK 210 3D 13C-FILTER NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 700 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : ARIA 2.2, SPARKY, VNMRJ, REMARK 210 TALOS, HADDOCK 2.0 REMARK 210 METHOD USED : SIMULATED ANNEALING, DGSA- REMARK 210 DISTANCE GEOMETRY SIMULATED REMARK 210 ANNEALING,DISTANCE GEOMETRY, REMARK 210 SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 18 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LEU A 6 -76.20 -130.11 REMARK 500 1 ARG A 29 136.98 64.94 REMARK 500 1 GLN A 44 -56.68 -138.22 REMARK 500 1 GLN A 67 84.06 58.77 REMARK 500 1 ASP A 68 -70.63 -117.09 REMARK 500 1 SER A 69 -55.60 -164.43 REMARK 500 1 LEU A 93 -48.40 -171.04 REMARK 500 1 ARG A 96 40.38 -142.74 REMARK 500 1 LYS A 97 69.27 -152.74 REMARK 500 1 LEU B 6 -128.46 -136.26 REMARK 500 1 ARG B 29 114.86 61.45 REMARK 500 1 GLN B 44 -52.79 -154.65 REMARK 500 1 GLN B 67 72.22 67.24 REMARK 500 1 ASP B 68 15.09 -140.05 REMARK 500 1 GLU B 86 38.84 -92.85 REMARK 500 1 LEU B 93 -49.72 -167.55 REMARK 500 1 LYS B 97 108.62 -162.85 REMARK 500 2 LEU A 6 -62.00 -135.61 REMARK 500 2 ARG A 29 120.40 64.76 REMARK 500 2 ASP A 31 54.73 -98.03 REMARK 500 2 GLN A 44 -63.37 -153.12 REMARK 500 2 LEU A 46 47.47 -140.60 REMARK 500 2 SER A 69 -66.71 70.34 REMARK 500 2 GLU A 86 33.99 -88.34 REMARK 500 2 LEU B 6 -153.22 -113.51 REMARK 500 2 VAL B 17 35.43 -99.92 REMARK 500 2 THR B 18 -47.88 -147.14 REMARK 500 2 ARG B 29 141.34 65.69 REMARK 500 2 ASP B 31 57.69 -92.87 REMARK 500 2 THR B 43 39.55 -98.83 REMARK 500 2 GLN B 44 -55.11 -163.66 REMARK 500 2 SER B 55 43.97 -104.91 REMARK 500 2 GLN B 67 77.65 62.29 REMARK 500 2 ASP B 68 -70.62 -129.06 REMARK 500 2 SER B 69 -50.53 -177.43 REMARK 500 2 ARG B 96 42.48 -148.51 REMARK 500 2 LYS B 97 115.29 -177.04 REMARK 500 3 LEU A 6 -58.03 -133.57 REMARK 500 3 VAL A 17 -72.26 -82.54 REMARK 500 3 ARG A 29 169.99 58.82 REMARK 500 3 GLN A 44 -60.95 -151.36 REMARK 500 3 LEU A 46 47.83 -142.22 REMARK 500 3 GLN A 67 89.41 64.78 REMARK 500 3 ASP A 68 -70.13 -141.16 REMARK 500 3 SER A 69 -58.78 -174.17 REMARK 500 3 ARG A 96 37.66 -144.75 REMARK 500 3 LYS A 97 70.67 -163.31 REMARK 500 3 LEU B 6 -59.24 -123.18 REMARK 500 3 ARG B 29 171.55 59.46 REMARK 500 3 GLN B 44 -58.98 -123.41 REMARK 500 REMARK 500 THIS ENTRY HAS 343 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ANW A 99 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ANW B 99 DBREF 2KOT A 1 98 UNP Q99584 S10AD_HUMAN 1 98 DBREF 2KOT B 1 98 UNP Q99584 S10AD_HUMAN 1 98 SEQRES 1 A 98 MET ALA ALA GLU PRO LEU THR GLU LEU GLU GLU SER ILE SEQRES 2 A 98 GLU THR VAL VAL THR THR PHE PHE THR PHE ALA ARG GLN SEQRES 3 A 98 GLU GLY ARG LYS ASP SER LEU SER VAL ASN GLU PHE LYS SEQRES 4 A 98 GLU LEU VAL THR GLN GLN LEU PRO HIS LEU LEU LYS ASP SEQRES 5 A 98 VAL GLY SER LEU ASP GLU LYS MET LYS SER LEU ASP VAL SEQRES 6 A 98 ASN GLN ASP SER GLU LEU LYS PHE ASN GLU TYR TRP ARG SEQRES 7 A 98 LEU ILE GLY GLU LEU ALA LYS GLU ILE ARG LYS LYS LYS SEQRES 8 A 98 ASP LEU LYS ILE ARG LYS LYS SEQRES 1 B 98 MET ALA ALA GLU PRO LEU THR GLU LEU GLU GLU SER ILE SEQRES 2 B 98 GLU THR VAL VAL THR THR PHE PHE THR PHE ALA ARG GLN SEQRES 3 B 98 GLU GLY ARG LYS ASP SER LEU SER VAL ASN GLU PHE LYS SEQRES 4 B 98 GLU LEU VAL THR GLN GLN LEU PRO HIS LEU LEU LYS ASP SEQRES 5 B 98 VAL GLY SER LEU ASP GLU LYS MET LYS SER LEU ASP VAL SEQRES 6 B 98 ASN GLN ASP SER GLU LEU LYS PHE ASN GLU TYR TRP ARG SEQRES 7 B 98 LEU ILE GLY GLU LEU ALA LYS GLU ILE ARG LYS LYS LYS SEQRES 8 B 98 ASP LEU LYS ILE ARG LYS LYS HET ANW A 99 35 HET ANW B 99 35 HETNAM ANW 2-AMINO-7-(1-METHYLETHYL)-5-OXO-5H-CHROMENO[2,3- HETNAM 2 ANW B]PYRIDINE-3-CARBOXYLIC ACID FORMUL 3 ANW 2(C16 H14 N2 O4) HELIX 1 1 THR A 7 ARG A 25 1 19 HELIX 2 2 ASN A 36 THR A 43 1 8 HELIX 3 3 LEU A 56 ASP A 64 1 9 HELIX 4 4 LYS A 72 LYS A 90 1 19 HELIX 5 5 THR B 7 ARG B 25 1 19 HELIX 6 6 ASN B 36 THR B 43 1 8 HELIX 7 7 LEU B 56 ASP B 64 1 9 HELIX 8 8 LYS B 72 GLU B 86 1 15 SITE 1 AC1 3 MET A 1 PHE A 21 ARG A 25 SITE 1 AC2 5 MET B 1 PHE B 21 THR B 22 LYS B 30 SITE 2 AC2 5 ASP B 31 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL MASTER 154 0 2 8 0 0 3 6 0 0 0 16 END